{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:26:13Z","timestamp":1789007173307,"version":"build-2803163510"},"reference-count":103,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T00:00:00Z","timestamp":1696896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>\n                    There is now evidence from multiple Phase II clinical trials that psychedelic drugs can exert long-lasting anxiolytic, anti-depressant, and anti-drug abuse (nicotine and ethanol) effects in patients. Despite these benefits, the hallucinogenic actions of these drugs at the serotonin 2A receptor (5-HT2AR) limit their clinical use in diverse settings. Activation of the 5-HT2AR can stimulate both G protein and\n                    <jats:italic>\u03b2<\/jats:italic>\n                    -arrestin (\u03b2Arr) -mediated signaling. Lisuride is a G protein biased agonist at the 5-HT2AR and, unlike the structurally-related lysergic acid diethylamide (LSD), the drug does not typically produce hallucinations in normal subjects at routine doses. Here, we examined behavioral responses to lisuride, in wild-type (WT), \u03b2Arr1-knockout (KO), and \u03b2Arr2-KO mice. In the open field, lisuride reduced locomotor and rearing activities, but produced a U-shaped function for stereotypies in both \u03b2Arr lines of mice. Locomotion was decreased overall in \u03b2Arr1-KOs and \u03b2Arr2-KOs relative to wild-type controls. Incidences of head twitches and retrograde walking to lisuride were low in all genotypes. Grooming was decreased in \u03b2Arr1 mice, but was increased then decreased in \u03b2Arr2 animals with lisuride. Serotonin syndrome-associated responses were present at all lisuride doses in WTs, but they were reduced especially in \u03b2Arr2-KO mice. Prepulse inhibition (PPI) was unaffected in \u03b2Arr2 mice, whereas 0.5\u00a0mg\/kg lisuride disrupted PPI in \u03b2Arr1 animals. The 5-HT2AR antagonist MDL100907 failed to restore PPI in \u03b2Arr1 mice, whereas the dopamine D2\/D3 antagonist raclopride normalized PPI in WTs but not in \u03b2Arr1-KOs. Clozapine, SCH23390, and GR127935 restored PPI in both \u03b2Arr1 genotypes. Using vesicular monoamine transporter 2 mice, lisuride reduced immobility times in tail suspension and promoted a preference for sucrose that lasted up to 2\u00a0days. Together, it appears \u03b2Arr1 and \u03b2Arr2 play minor roles in lisuride\u2019s actions on many behaviors, while this drug exerts anti-depressant drug-like responses without hallucinogenic-like activities.\n                  <\/jats:p>","DOI":"10.3389\/fmolb.2023.1233743","type":"journal-article","created":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:15:53Z","timestamp":1696929353000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["The G protein biased serotonin 5-HT2A receptor agonist lisuride exerts anti-depressant drug-like activities in mice"],"prefix":"10.3389","volume":"10","author":[{"given":"Vladimir M.","family":"Pogorelov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona M.","family":"Rodriguiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan L.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Wetsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1037\/\/0735-7044.99.5.881","article-title":"A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats","volume":"99","author":"Adams","year":"1985","journal-title":"Behav. Neurosci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"18488","DOI":"10.1073\/pnas.1104807108","article-title":"Discovery of \u03b2-arrestin-biased dopamine D2 ligands for probing signal transduction pathways essential for antipsychotic efficacy","volume":"108","author":"Allen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. (USA)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1523\/JNEUROSCI.12-10-04045.1992","article-title":"The G-protein-coupled receptor kinases \u03b2ARK1 and \u03b2ARK2 are widely distributed at synapses in rat brain","volume":"12","author":"Arriza","year":"1992","journal-title":"J. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.cell.2005.05.012","article-title":"An Akt\/\u03b2-arrestin 2\/PP2A signaling complex mediates dopaminergic neurotransmission and behavior","volume":"122","author":"Beaulieu","year":"2005","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8269","DOI":"10.1074\/jbc.M006968200","article-title":"The dynamin-dependent, arrestin-independent internalization of 5-hydroxytryptamine 2A (5-HT2A) serotonin receptors reveals differential sorting of arrestins and 5-HT2A receptors during endocytosis","volume":"276","author":"Bhatnagar","year":"2001","journal-title":"J. Biol. Chem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.pnpbp.2015.03.002","article-title":"Classic hallucinogens in the treatment of addictions","volume":"64","author":"Bogenschutz","year":"2016","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking \u03b2-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/0166-4328(96)00102-7","article-title":"Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium","volume":"73","author":"Bonson","year":"1996","journal-title":"Behav. Brain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s002130100810","article-title":"Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies","volume":"156","author":"Braff","year":"2001","journal-title":"Psychopharmacol. Berl."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e48912","DOI":"10.1371\/journal.pone.0048912","article-title":"Distinct cellular and subcellular distributions of G protein-coupled receptor kinase and arrestin isoforms in the striatum","volume":"7","author":"Bychkov","year":"2012","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1126\/science.abl8615","article-title":"Structure-based discovery of nonhallucinogenic psychedelic analogs","volume":"375","author":"Cao","year":"2022","journal-title":"Science"},{"key":"B12","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0028-3908(85)90074-7","article-title":"Tolerance to some behavioural effects of lisuride, a dopamine receptor agonist, and reverse tolerance to others, after repeated administration","volume":"24","author":"Carruba","year":"1985","journal-title":"Neuropharmacology"},{"key":"B14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0014-2999(80)90036-9","article-title":"Anorectic effect of lisuride and other ergot derivatives in the rat","volume":"64","author":"Carruba","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1021729","DOI":"10.3389\/fphar.2023.1021729","article-title":"Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00401509","article-title":"A possible correlation between drug-induced hallucinations in man and a behavioural response in mice","volume":"11","author":"Corne","year":"1967","journal-title":"Psychopharmacologia"},{"key":"B17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ejphar.2008.07.040","article-title":"Agonist-directed trafficking of signaling at serotonin 5-HT2A, 5-HT2B and 5-HT2CVSV receptors mediated Gq\/11 activation and calcium mobilization in CHO cells","volume":"594","author":"Cussac","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s0091-3057(97)00548-0","article-title":"Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice","volume":"60","author":"Darmani","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s007020070043","article-title":"Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice","volume":"107","author":"Darmani","year":"2000","journal-title":"J. Neural Transm."},{"key":"B20","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s002130050585","article-title":"Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors","volume":"136","author":"Egan","year":"1998","journal-title":"Psychopharmacol. Berl."},{"key":"B21","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1073\/pnas.93.10.5166","article-title":"Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter","volume":"93","author":"Erickson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1073\/pnas.87.6.2187","article-title":"Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositol phospholipid hydrolysis","volume":"87","author":"Felder","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/0091-3057(92)90212-x","article-title":"Effects of the dopamine D2 agonists lisuride and CQ 32-084 on rat feeding behavior","volume":"41","author":"Ferrari","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B24","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/BF00429666","article-title":"Locomotor effects of lisuride: a consequence of dopaminergic and serotonergic actions","volume":"85","author":"Fink","year":"1985","journal-title":"Psychopharmacol. Berl."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1056\/nejm195412162512504","article-title":"Mental depression in hypertensive patients treated for long periods with large doses of reserpine","volume":"251","author":"Freis","year":"1954","journal-title":"N. Engl. J. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"10520","DOI":"10.1523\/JNEUROSCI.4388-06.2007","article-title":"Vmat2 heterozygous mutant mice display a depressive-like phenotype","volume":"27","author":"Fukui","year":"2007","journal-title":"J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1177\/0269881114555249","article-title":"LSD-assisted psychotherapy for anxiety associated with a life threatening disease: a qualitative study of acute and sustained subjective effects","volume":"29","author":"Gasser","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1046\/j.1471-4159.1999.0722206.x","article-title":"Structure and function of the third intracellular loop of the 5-hydroxytryptamine2A receptor: the third intracellular loop is alpha-helical and binds purified arrestins","volume":"72","author":"Gelber","year":"1999","journal-title":"J. Neurochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/0304-3940(85)90245-9","article-title":"Antagonism of L-5-hydroxytryptophan-induced head twitching in rats by lisuride: a mixed 5-hydroxytryptamine agonist-antagonist?","volume":"60","author":"Gerber","year":"1985","journal-title":"Neurosci. Lett."},{"key":"B30","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.tips.2008.06.006","article-title":"Serotonin research: contributions to understanding psychoses","volume":"29","author":"Geyer","year":"2008","journal-title":"Trends Pharmacol. Sci."},{"key":"B31","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1016\/0024-3205(84)90436-3","article-title":"Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic drugs","volume":"35","author":"Glennon","year":"1984","journal-title":"Life Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0014-2999(83)90464-8","article-title":"Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists","volume":"91","author":"Glennon","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.neuron.2007.01.008","article-title":"Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior","volume":"53","author":"Gonz\u00e1lez-Maeso","year":"2007","journal-title":"Neuron"},{"key":"B34","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jad.2023.01.108","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression: impact on patient-reported depression severity, anxiety, function, and quality of life","volume":"327","author":"Goodwin","year":"2023","journal-title":"J. Affect Disord."},{"key":"B35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1001\/archneurpsyc.1958.02340020088016","article-title":"Psychopathology and psychophysiology of minimal LSD-25 dosage; a preliminary dosage-response spectrum","volume":"79","author":"Greiner","year":"1958","journal-title":"AMA Arch. Neurol. Psychiatry"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"111211","DOI":"10.1016\/j.celrep.2022.111211","article-title":"Molecular insights into the regulation of constitutive activity by RNA editing of the 5HT2Cserotonin receptors","volume":"40","author":"Gumpper","year":"1922","journal-title":"Cell Rep."},{"key":"B38","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/s0306-4522(01)00511-5","article-title":"Arrestin 2 and arrestin 3 are differentially expressed in the rat brain during postnatal development","volume":"109","author":"Gurevich","year":"2002","journal-title":"Neuroscience"},{"key":"B39","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbr.2013.08.045","article-title":"Animal models of the serotonin syndrome: A systematic review","volume":"256","author":"Habertzettl","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacol. Berl."},{"key":"B42","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00213-009-1718-x","article-title":"LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT2A receptor","volume":"208","author":"Halberstadt","year":"2010","journal-title":"Psychopharmacol. Berl."},{"key":"B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/fpj.80.1","article-title":"Effects of an ergot derivative, lisuride, on the central dopaminergic system \u2013 studies of behavioral pharmacology","volume":"80","author":"Hara","year":"1982","journal-title":"Nihon Yakurigaku Zasshi"},{"key":"B44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/j.1526-4610.1977.hed1702054.x","article-title":"Clinical effectiveness of lisuride hydrogen maleate: a double-blind trial versus methysergide","volume":"17","author":"Herrmann","year":"1977","journal-title":"Headache"},{"key":"B45","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF00427818","article-title":"Effects of lisuride on precopulatory and copulatory behaviour of adult male rats","volume":"79","author":"Hlin\u00e1k","year":"1983","journal-title":"Psychopharmacol. Berl."},{"key":"B46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic acid diethylamide-assisted therapy in patients with anxiety with and without a life-threatening illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"B47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0014-2999(76)90091-1","article-title":"Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice","volume":"36","author":"Horowski","year":"1976","journal-title":"Eur. J. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3143\/geriatrics.31.52","article-title":"[Therapeutic effect of lisuride maleate on post-stroke depression","volume":"31","author":"Hougaku","year":"1994","journal-title":"Nihon Ronen Igakkai Zasshi"},{"key":"B49","first-page":"157","article-title":"International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin)","volume":"46","author":"Hoyer","year":"1994","journal-title":"Pharmacol. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/0091-3057(95)00160-x","article-title":"Prepulse inhibition of acoustic startle, a measure of sensorimotor gating: effects of antipsychotics and other agents in rats","volume":"52","author":"Johansson","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B51","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/s41586-022-05258-z","article-title":"Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity","volume":"610","author":"Kaplan","year":"2022","journal-title":"Nature"},{"key":"B52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","article-title":"Predicting new molecular targets for known drugs","volume":"462","author":"Keiser","year":"2009","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/s0165-6147(00)89032-x","article-title":"Agonist-receptor efficacy. II. Agonist trafficking of receptor signals","volume":"16","author":"Kenakin","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13395-018-0184-8","article-title":"\u03b2-Arrestin 1 regulates \u03b22-adrenergic receptor-mediated skeletal muscle hypertrophy and contractility","volume":"8","author":"Kim","year":"2018","journal-title":"Skelet. Muscle"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT2A serotonin receptor","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"B56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nsmb.3014","article-title":"PRESTO-Tango as an open source resource for interrogation of the druggable human GPCRome","volume":"22","author":"Kroeze","year":"2015","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1124\/jpet.102.042184","article-title":"Serotonin 5-hydroxytryptamine2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves","volume":"304","author":"Kurrasch-Orbaugh","year":"2003","journal-title":"J. Pharrmacol Exp. Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bbr.2015.08.018","article-title":"Effects of LSD on grooming behavior in serotonin transporter heterozygous (Sert+\/-) mice","volume":"296","author":"Kyzar","year":"2016","journal-title":"Behav. Brain Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1136\/jnnp.44.4.347","article-title":"The use of lisuride in the treatment of multiple system atrophy with autonomic failure","volume":"44","author":"Lees","year":"1981","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/wnl.32.1.69","article-title":"Lisuride versus bromocriptine treatment in parkinson diseases: a double-blind study","volume":"32","author":"LeWitt","year":"1982","journal-title":"Neurology"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000284842","article-title":"Evidence for the existence of major depression with and without anxiety features","volume":"27","author":"Maes","year":"1994","journal-title":"Psychopathology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0091-3057(77)90032-6","article-title":"Quipazine-induced head-twitch in mice","volume":"6","author":"Malick","year":"1977","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00213-002-1141-z","article-title":"Re-evaluation of lisuride pharmacology: 5 hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats","volume":"164","author":"Marona-Lewicka","year":"2002","journal-title":"Psychopharmacol. Berl."},{"key":"B64","first-page":"706","article-title":"Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation","volume":"229","author":"Martin","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41573-022-00421-7","article-title":"The promises and perils of psychedelic pharmacology for psychiatry","volume":"21","author":"McClure-Begley","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"B66","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000115567","article-title":"Lisuride in the treatment of parkinsonism","volume":"22","author":"McDonald","year":"1983","journal-title":"Eur. Neurol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1172\/JCI70678","article-title":"Lorcaserin and pimavanserin: emerging selectivity of serotonin receptor subtype-targeted drugs","volume":"123","author":"Meltzer","year":"2013","journal-title":"J. Clin. Invest."},{"key":"B68","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1124\/jpet.102.039867","article-title":"Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding properties of 14 drugs at 21 native and cloned human receptor subtypes","volume":"303","author":"Millan","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B69","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0014-2999(92)90212-m","article-title":"Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats","volume":"216","author":"Nisoli","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0893-133X(01)00282-2","article-title":"Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains","volume":"25","author":"Ouagazzal","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.pnpbp.2010.02.008","article-title":"Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition","volume":"34","author":"P\u00e1len\u00ed\u010dek","year":"2010","journal-title":"Prog. Neuropsychopharmaco. Biol. Psychiatry"},{"key":"B72","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410090109","article-title":"Lisuride in parkinsonism","volume":"9","author":"Parkes","year":"1981","journal-title":"Ann. Neurol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF02244547","article-title":"A temporal and spatial scaling hypothesis for the behavioral effects of psychostimulants","volume":"104","author":"Paulus","year":"1991","journal-title":"Psychopharmacol. Berl."},{"key":"B74","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0014-2999(96)00454-2","article-title":"Inhibition of dopamine neuron firing by pramipexole, a dopamine D3 receptor-preferring agonist: comparison to other dopamine receptor agonists","volume":"312","author":"Piercey","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1526-4610.1983.hed2303117.x","article-title":"Lisuride in cluster headaches","volume":"23","author":"Raffaelli","year":"1983","journal-title":"Headache"},{"key":"B76","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1124\/jpet.104.074468","article-title":"Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of sprague-dawley rats to Swiss-webster, 129x1\/SvJ, C57bl\/6J, and DBA\/2J mice","volume":"312","author":"Ralph","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B77","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1176\/appi.ajp.2019.19010035","article-title":"Psychedelics and psychedelic-assisted psychotherapy","volume":"177","author":"Reiff","year":"2020","journal-title":"Am. J. Psychiatry"},{"key":"B78","doi-asserted-by":"publisher","first-page":"17690","DOI":"10.1038\/s41598-021-96736-3","article-title":"LSD-stimulated behaviors in mice require \u03b2-arrestin 2 but not \u03b2-arrestin 1","volume":"11","author":"Rodriguiz","year":"2021","journal-title":"Sci. Rep."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/0024-3205(87)90621-7","article-title":"Multiple mechanisms of serotonin signal transduction","volume":"41","author":"Roth","year":"1987","journal-title":"Life Sci."},{"key":"B81","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrd1346","article-title":"Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia","volume":"3","author":"Roth","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/s0140-6736(79)92523-6","article-title":"Lisuride in Parkinson's disease","volume":"2","author":"Schachter","year":"1979","journal-title":"Lancet"},{"key":"B83","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am. J. Psychiatry"},{"key":"B84","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"B85","first-page":"101","article-title":"(1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-ht2a\/2C antagonists, D1 antagonists and 5-ht1a agonists","volume":"273","author":"Schreiber","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1212\/01.wnl.0000219761.05466.43","article-title":"Response to cluster headache to psilocybin and LSD","volume":"66","author":"Sewell","year":"2006","journal-title":"Neurology"},{"key":"B87","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF00492209","article-title":"Lisuride and LSD: dopaminergic and serotonergic interactions in the serotonin syndrome","volume":"65","author":"Silbergeld","year":"1979","journal-title":"Psychopharmacol. Berl."},{"key":"B88","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/0028-3908(94)90074-4","article-title":"Multiple serotonin receptor subtypes modulate prepulse inhibition of the startle response in rats","volume":"33","author":"Sipes","year":"1994","journal-title":"Neuropharmacology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1526-4610.1978.hed1802075.x","article-title":"Migraine prophylaxis with lisuride hydrogen maleate - a double blind study of lisuride versus placebo","volume":"18","author":"Somerville","year":"1978","journal-title":"Headache"},{"key":"B90","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/BF02260968","article-title":"Potentiation of dopamine-dependent locomotion by clonidine in reserpine-treated mice is restricyed to D2 agonists","volume":"7","author":"Starr","year":"1994","journal-title":"J. Neural Transm. Park Dis. Dement. Sect."},{"key":"B91","doi-asserted-by":"publisher","first-page":"e0211239","DOI":"10.1371\/journal.pone.0211239","article-title":"Dissecting the roles of \u03b2-arrestin 2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice","volume":"14","author":"Thompson","year":"2019","journal-title":"PLoS One"},{"key":"B92","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/bmj.289.6452.1101","article-title":"Psychotic reactions during treatment of pituitary tumours with dopamine agonists","volume":"289","author":"Turner","year":"1984","journal-title":"Br. Med. J. Clin. Res. Ed."},{"key":"B93","doi-asserted-by":"publisher","first-page":"E8178","DOI":"10.1073\/pnas.1614347113","article-title":"Distinct cortical and striatal actions of a \u03b2-arrestin-biased dopamine D2 receptor ligand reveal novel antipsychotic-like properties","volume":"113","author":"Urs","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B94","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/brain\/114.1.601","article-title":"Subcutaneous lisuride infusion in Parkinson's disease. Response to chronic administration in 34 patients","volume":"114","author":"Vaamonde","year":"1991","journal-title":"Brain"},{"key":"B95","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/BF03349379","article-title":"Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states","volume":"3","author":"Verde","year":"1980","journal-title":"J. Endocrinol. Invest."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/sj.npp.1301324","article-title":"The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval","volume":"32","author":"Vollenweider","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"B97","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.2042-7158.1983.tb04318.x","article-title":"Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo","volume":"35","author":"Wachtel","year":"1983","journal-title":"J. Pharm. Pharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1126\/science.1232808","article-title":"Structural features for functional selectivity at serotonin receptors","volume":"340","author":"Wacker","year":"2013","journal-title":"Science"},{"key":"B99","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.cell.2016.12.033","article-title":"Crystal structure of an LSD-bound human serotonin receptor","volume":"168","author":"Wacker","year":"2017","journal-title":"Cell"},{"key":"B100","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1126\/science.1232807","article-title":"Structural basis for molecular recognition at serotonin receptors","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/s0896-6273(00)80419-5","article-title":"Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine","volume":"19","author":"Wang","year":"1997","journal-title":"Neuron"},{"key":"B102","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/s41594-022-00796-6","article-title":"Inactive and active state structures template selective tools for the human 5-HT5A receptor. Nat","volume":"29","author":"Zhang","year":"2022","journal-title":"Struct. Mol. Biol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1135\/cccc19601922","article-title":"Mutterkornalkaloide XVI. Einige N-(D-6-methylisoergolenyl-8)-,N-(D-6-methylergolenyl-8)- und N-(D-6-methylergolin(I)-yl-8)-N'-substituierte harnstoffe","volume":"25","author":"Zik\u00e1n","year":"1960","journal-title":"Collect. Czechoslov. Chem. Commun."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1233743\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T09:16:00Z","timestamp":1696929360000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2023.1233743\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,10]]},"references-count":103,"alternative-id":["10.3389\/fmolb.2023.1233743"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2023.1233743","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,10]]},"article-number":"1233743"}}